Aclarion Stock Today
| ACON Stock | USD 8.40 0.81 8.79% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Aclarion is selling at 8.40 as of the 30th of January 2025; that is 8.79 percent decrease since the beginning of the trading day. The stock's open price was 9.21. Aclarion has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 22nd of April 2022 | Category Healthcare | Classification Health Care |
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. The company has 69.31 K outstanding shares of which 7.75 M shares are presently shorted by private and institutional investors with about 0.77 trading days to cover. More on Aclarion
Moving against Aclarion Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aclarion Stock Highlights
| President CEO | Brent Ness | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAclarion can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aclarion's financial leverage. It provides some insight into what part of Aclarion's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Aclarion (ACON) is traded on NASDAQ Exchange in USA. It is located in 8181 Arista Place, Broomfield, CO, United States, 80021 and employs 4 people. Aclarion is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.91 K. Aclarion conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 69.31 K outstanding shares of which 7.75 M shares are presently shorted by private and institutional investors with about 0.77 trading days to cover.
Aclarion currently holds about 3.79 M in cash with (3.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49.
Check Aclarion Probability Of Bankruptcy
Ownership AllocationAclarion shows 9.76 percent of its outstanding shares held by insiders and 3.57 percent owned by other corporate entities.
Check Aclarion Ownership Details
Aclarion Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Two Sigma Securities, Llc | 2024-09-30 | 49.3 K | |
| Hrt Financial Llc | 2024-06-30 | 0.0 | |
| Ubs Group Ag | 2024-09-30 | 40 K | |
| Geode Capital Management, Llc | 2024-09-30 | 33.9 K | |
| Susquehanna International Group, Llp | 2024-09-30 | 14.2 K | |
| Jane Street Group Llc | 2024-09-30 | 12.2 K | |
| Tower Research Capital Llc | 2024-09-30 | 9.2 K | |
| Bank Of America Corp | 2024-09-30 | 70.0 | |
| Ground Swell Capital, Llc | 2024-09-30 | 0.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Virtu Financial Llc | 2024-06-30 | 0.0 |
Aclarion Historical Income Statement
Aclarion Stock Against Markets
Already Invested in Aclarion?
The danger of trading Aclarion is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aclarion is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aclarion. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aclarion is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (804.49) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.